-
-
-
-
-
-
-
BioLineRx (BLRX) Issues Letter to Shareholders
-
-
-
-
-
-
-
Renexxion Ireland Announces Issuance of Two U.S. Patents Covering a Novel Crystal Isoform of Naronapride
-
-
-
-
-
-
-
Chemomab Therapeutics Presents Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2023
-
-
-
-
-
-
-
Patient Data Presented at 2023 EULAR Congress Highlights How Serum CCL24 Levels Can Predict Vascular and Fibrotic Complications of Systemic Sclerosis
-
-
-
-
-
-
-
Tiziana Life Sciences (TLSA) to File Alzheimer’s IND for Intranasal Foralumab in Q2 2023
-
-
-
-
-
-
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
-
-
-
-
-
-
Chemomab Therapeutics to Discuss First Quarter 2023 Financial Results and Provide a Corporate Update
-
742 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


